{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T15:30:43Z","timestamp":1779895843952,"version":"3.53.1"},"reference-count":138,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.clindermatol.2011.08.005","type":"journal-article","created":{"date-parts":[[2011,10,20]],"date-time":"2011-10-20T05:37:23Z","timestamp":1319089043000},"page":"678-690","source":"Crossref","is-referenced-by-count":25,"title":["Injectable neurotoxins and fillers: There is no free lunch"],"prefix":"10.1016","volume":"29","author":[{"given":"Jason","family":"Emer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Waldorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2011.08.005_bb0005","author":"American Society of Plastic Surgeons"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0010","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.sder.2006.12.004","article-title":"Complications with the use of botulinum toxin type A for cosmetic applications and hyperhidrosis","volume":"26","author":"Pena","year":"2007","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0015","author":"Allergan"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0020","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1001\/jama.296.20.2476","article-title":"Botulism in 4 adults following cosmetic injections with an unlicensed, highly concentrated botulinum preparation","volume":"296","author":"Chertow","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0025","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/mds.870030409","article-title":"Systemic toxicity of botulinum toxin by intramuscular injection in the monkey","volume":"3","author":"Scott","year":"1988","journal-title":"Mov Disord"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0030","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1067\/mjd.2000.105567","article-title":"Pharmacology of botulinum toxin","volume":"43","author":"Huang","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0035","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.1002\/(SICI)1097-4598(1997)6+<146::AID-MUS10>3.0.CO;2-4","article-title":"Botulinum toxin: chemistry, pharmacology, toxicity, and immunology","volume":"6","author":"Brin","year":"1997","journal-title":"Muscle Nerve Suppl"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0040","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2147\/CIA.S9338","article-title":"Treating glabellar lines with botulinum toxin type A-hemagglutinin complex: a review of the science, the clinical data, and patient satisfaction","volume":"5","author":"De Boulle","year":"2010","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0050","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1212\/WNL.53.7.1439","article-title":"Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia","volume":"53","author":"Brashear","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0055","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1212\/WNL.53.7.1431","article-title":"Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia","volume":"53","author":"Brin","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0060","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1046\/j.1524-4725.2003.29124.x","article-title":"Botulinum toxin type B (MYOBLOC) versus botulinum toxin type A (BOTOX) frontalis study: rate of onset and radius of diffusion","volume":"29","author":"Flynn","year":"2003","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0065","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1046\/j.1524-4725.2003.29123.x","article-title":"Botulinum toxin type B for dynamic glabellar rhytides refractory to botulinum toxin type A","volume":"29","author":"Alster","year":"2003","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0070","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1524-4725.2003.29122.x","article-title":"Prospective open-label study of botulinum toxin type B (Myobloc) at doses of 2,400 and 3,000 U for the treatment of glabellar wrinkles","volume":"29","author":"Sadick","year":"2003","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0075","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/14764170260030126","article-title":"Botulinum B treatment of the glabellar and frontalis regions: a dose response analysis","volume":"4","author":"Spencer","year":"2002","journal-title":"J Cosmet Laser Ther"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0080","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1046\/j.1524-4725.2003.29132.x","article-title":"A double-blinded, randomized, placebo-controlled pilot study of the safety and efficacy of Myobloc (botulinum toxin type B)-purified neurotoxin complex for the treatment of crow's feet: a double-blinded, placebo-controlled trial","volume":"29","author":"Baumann","year":"2003","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0085","doi-asserted-by":"crossref","first-page":"88S","DOI":"10.1097\/01.PRS.0000082197.88799.84","article-title":"The role of botulinum toxin type B (Myobloc) in the treatment of hyperkinetic facial lines","volume":"112","author":"Kim","year":"2003","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0090","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/sder.2003.50009","article-title":"Botulinum neurotoxin type B\u2014a rapid wrinkle reducer","volume":"22","author":"Jacob","year":"2003","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0095","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1046\/j.1524-4725.2003.29120.x","article-title":"Botulinum toxin type B (Myobloc)","volume":"29","author":"Baumann","year":"2003","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0100","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.clindermatol.2003.11.005","article-title":"Botulinum toxin types A and B: comparison of efficacy, duration, and dose-ranging studies for the treatment of facial rhytides and hyperhidrosis","volume":"22","author":"Yamauchi","year":"2004","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0105","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.clindermatol.2003.12.033","article-title":"The cosmetic use of botulinum toxin type B in the upper face","volume":"22","author":"Sadick","year":"2004","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0110","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1053\/mda.2001.25964","article-title":"Complications and adverse reactions with the use of botulinum toxin","volume":"48","author":"Klein","year":"2002","journal-title":"Dis Mon"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0115","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1053\/sder.2001.25964","article-title":"Complications and adverse reactions with the use of botulinum toxin","volume":"20","author":"Klein","year":"2001","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0120","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1046\/j.1524-4725.2003.29129.x","article-title":"Complications, adverse reactions, and insights with the use of botulinum toxin","volume":"29","author":"Klein","year":"2003","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0125","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2165\/00128071-200506030-00001","article-title":"Managing adverse events associated with botulinum toxin type A: a focus on cosmetic procedures","volume":"6","author":"Wollina","year":"2005","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0130","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1067\/mjd.2002.124070","article-title":"Bilateral, double-blind, randomized comparison of 3 doses of botulinum toxin type A and placebo in patients with crow's feet","volume":"47","author":"Lowe","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0135","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1524-4725.2005.31726","article-title":"Dietary supplements: altered coagulation and effects on bruising","volume":"31","author":"Dinehart","year":"2005","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0140","doi-asserted-by":"crossref","first-page":"48e","DOI":"10.1097\/01.prs.0000252661.72071.8d","article-title":"Use of herbal supplements and vitamins in plastic surgery: a practical review","volume":"119","author":"Broughton","year":"2007","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0145","first-page":"20","article-title":"Dietary supplements in primary care. Botanicals can affect surgical outcomes and follow-up","volume":"59","author":"Ciocon","year":"2004","journal-title":"Geriatrics"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0150","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S1076-0512(98)00187-3","article-title":"Complications of botulinum A exotoxin for hyperfunctional lines","volume":"24","author":"Matarasso","year":"1998","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0155","first-page":"359","article-title":"Nutritional support for wound healing","volume":"8","author":"MacKay","year":"2003","journal-title":"Altern Med Rev"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0160","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.2146\/ajhp070155","article-title":"Arnica for bruising and swelling","volume":"64","author":"Kouzi","year":"2007","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0165","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.2310\/6350.2005.31304","article-title":"Single-center, double-blind, randomized study to evaluate the efficacy of 4% lidocaine cream versus vehicle cream during botulinum toxin type A treatments","volume":"31","author":"Carruthers","year":"2005","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0170","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/IOP.0b013e3181b1e526","article-title":"Comparison of pain scores with 30-gauge and 32-gauge needles for periocular botulinum toxin type a injections","volume":"25","author":"Yomtoob","year":"2009","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0175","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1159\/000066186","article-title":"Anesthesia with EMLA cream for botulinum A toxin injection into eyelids","volume":"216","author":"S\u00f6ylev","year":"2002","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0180","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/00002341-200211000-00010","article-title":"Skin cooling before periocular botulinum toxin A injection","volume":"18","author":"Linder","year":"2002","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0185","first-page":"325","article-title":"Cosmetic uses of botulinum A exotoxin","volume":"12","author":"Carruthers","year":"1997","journal-title":"Adv Dermatol"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0190","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1064-7406(02)00045-7","article-title":"Hypersensitivity reactions to products and devices in plastic surgery","volume":"11","author":"Cohen","year":"2003","journal-title":"Facial Plast Surg Clin North Am"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0195","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1520\/JFS2004196","article-title":"Fatal case of BOTOX-related anaphylaxis?","volume":"50","author":"Li","year":"2005","journal-title":"J Forensic Sci"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0200","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1067\/mjd.2001.118342","article-title":"Severe, intractable headache after injection with botulinum a exotoxin: report of 5 cases","volume":"46","author":"Alam","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0205","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.clindermatol.2003.12.026","article-title":"Contraindications and complications with the use of botulinum toxin","volume":"22","author":"Klein","year":"2004","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0210","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1177\/0333102410364676","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial","volume":"30","author":"Aurora","year":"2010","journal-title":"Cephalalgia"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0215","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1177\/0333102410364677","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial","volume":"30","author":"Diener","year":"2010","journal-title":"Cephalalgia"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0225","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/01.PRS.0000076504.79727.62","article-title":"Double-blind, placebo-controlled study of the safety and efficacy of botulinum toxin type A for patients with glabellar lines","volume":"112","author":"Carruthers","year":"2003","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0230","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1468-3083.2004.00934.x","article-title":"Evaluation of the safety of a non-animal stabilized hyaluronic acid (NASHA\u2014Q-Medical, Sweden) in European countries: a retrospective study from 1997 to 2001","volume":"18","author":"Andr\u00e9","year":"2004","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0235","doi-asserted-by":"crossref","first-page":"i","DOI":"10.1097\/01.PRS.0000146690.73307.EF","article-title":"Introduction to the consensus recommendations","volume":"114","author":"Carruthers","year":"2004","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0240","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1097\/01.PRS.0000144795.76040.D3","article-title":"Consensus recommendations on the use of botulinum toxin type a in facial aesthetics","volume":"114","author":"Carruthers","year":"2004","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0245","first-page":"S13","article-title":"Guidelines on the use of botulinum toxin type A","volume":"74","author":"Shetty","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0250","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1524-4725.2006.32035.x","article-title":"Multicenter study of the efficacy and safety of subcutaneous non-animal-stabilized hyaluronic acid in aesthetic facial contouring: interim report","volume":"32","author":"DeLorenzi","year":"2006","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0255","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archfaci.8.2.92","article-title":"Use of radiesse in combination with restylane for facial augmentation","volume":"8","author":"Godin","year":"2006","journal-title":"Arch Facial Plast Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0260","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.sder.2006.06.005","article-title":"Calcium hydroxylapatite for facial rejuvenation","volume":"25","author":"Berlin","year":"2006","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0265","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/IOP.0b013e3181b81082","article-title":"Skin necrosis after calcium hydroxylapatite injection into the glabellar and nasolabial folds","volume":"25","author":"Georgescu","year":"2009","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0270","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1524-4725.2006.32052.x","article-title":"Injection necrosis of the glabella: protocol for prevention and treatment after use of dermal fillers","volume":"32","author":"Glaich","year":"2006","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0275","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1111\/j.1524-4725.2009.01341.x","article-title":"The spectrum of adverse reactions after treatment with injectable fillers in the glabellar region: results from the Injectable Filler Safety Study","volume":"35","author":"Bachmann","year":"2009","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0280","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1524-4725.2005.31709","article-title":"NewFill for skin augmentation: a new filler or failure?","volume":"31","author":"Beljaards","year":"2005","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0285","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1046\/j.1524-4725.2003.29262.x","article-title":"Outbreak of Mycobacterium abscessus infection after soft tissue augmentation","volume":"29","author":"Toy","year":"2003","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0290","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/01.prs.0000300188.82515.7f","article-title":"Arterial embolization and skin necrosis of the nasal ala following injection of dermal fillers","volume":"121","author":"Inoue","year":"2008","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0295","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.joms.2008.01.052","article-title":"Granulomatous foreign-body reaction involving oral and perioral tissues after injection of biomaterials: a series of 7 cases and review of the literature","volume":"67","author":"Jham","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0300","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1524-4725.2005.31166","article-title":"Angioedema acute hypersensitivity reaction to injectable hyaluronic acid","volume":"31","author":"Leonhardt","year":"2005","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0305","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1136\/jcp.2007.048330","article-title":"Granulomatous reaction to injectable hyaluronic acid (Restylane) diagnosed by fine needle biopsy","volume":"60","author":"Al-Shraim","year":"2007","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0310","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1365-2133.2005.07074.x","article-title":"Cutaneous granulomatous reaction to injectable hyaluronic acid gel","volume":"154","author":"Ghislanzoni","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0315","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/DAD.0b013e318194816d","article-title":"Foreign body granuloma due to Matridex injection for cosmetic purposes","volume":"31","author":"Massone","year":"2009","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0320","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1524-4725.2006.32086.x","article-title":"Clinical conference: management of rare events following dermal fillers\u2014focal necrosis and angry red bumps","volume":"32","author":"Narins","year":"2006","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0325","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1540-9740.2005.04061.x","article-title":"A histologic study of adverse effects of different cosmetic skin fillers","volume":"4","author":"Parada","year":"2005","journal-title":"Skinmed"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0330","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1524-4725.2007.33073.x","article-title":"Successful management of an unusual presentation of impending necrosis following a hyaluronic acid injection embolus and a proposed algorithm for management with hyaluronidase","volume":"33","author":"Hirsch","year":"2007","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0335","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/IOP.0b013e318070d773","article-title":"Management of visible granulomas following periorbital injection of poly-L-lactic Acid","volume":"23","author":"Stewart","year":"2007","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0340","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1055\/s-0029-1220653","article-title":"The management of dermal filler complications","volume":"25","author":"Winslow","year":"2009","journal-title":"Facial Plast Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0345","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1111\/j.1524-4725.2009.01323.x","article-title":"Filler injection with micro-cannula instead of needles","volume":"35","author":"Niamtu","year":"2009","journal-title":"Dermatol Surg"},{"issue":"Suppl 2","key":"10.1016\/j.clindermatol.2011.08.005_bb0350","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1111\/j.1524-4725.2009.01346.x","article-title":"Treatment of injectable soft tissue filler complications","volume":"35","author":"Sclafani","year":"2009","journal-title":"Dermatol Surg"},{"issue":"Suppl 2","key":"10.1016\/j.clindermatol.2011.08.005_bb0355","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1111\/j.1524-4725.2009.01336.x","article-title":"The nature of long-term fillers and the risk of complications","volume":"35","author":"Monheit","year":"2009","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0360","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1600-0560.2007.00853.x","article-title":"Adverse cutaneous reactions to soft tissue fillers\u2014a review of the histological features","volume":"35","author":"Dadzie","year":"2008","journal-title":"J Cutan Pathol"},{"issue":"Suppl 3","key":"10.1016\/j.clindermatol.2011.08.005_bb0365","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/j.1524-4725.2010.01743.x","article-title":"Comparison of the rheological properties of viscosity and elasticity in two categories of soft tissue fillers: calcium hydroxylapatite and hyaluronic acid","volume":"36","author":"Sundaram","year":"2010","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0370","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1001\/archfacial.2008.538","article-title":"Pulsed-dye laser for treating ecchymoses after facial cosmetic procedures","volume":"11","author":"DeFatta","year":"2009","journal-title":"Arch Facial Plast Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0375","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.asj.2006.04.002","article-title":"Treatment options for dermal filler complications","volume":"26","author":"Lemperle","year":"2006","journal-title":"Aesthet Surg J"},{"issue":"Suppl 1","key":"10.1016\/j.clindermatol.2011.08.005_bb0380","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1111\/j.1524-4725.2008.34249.x","article-title":"Understanding, avoiding, and managing dermal filler complications","volume":"34","author":"Cohen","year":"2008","journal-title":"Dermatol Surg"},{"issue":"Suppl 1","key":"10.1016\/j.clindermatol.2011.08.005_bb0385","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1111\/j.1524-4725.2008.34253.x","article-title":"ASDS guidelines of care: injectable fillers","volume":"34","author":"Alam","year":"2008","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0390","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1001\/archotol.1984.00800280027008","article-title":"Clinical use of injectable collagen. A three-year retrospective review","volume":"110","author":"Kamer","year":"1984","journal-title":"Arch Otolaryngol"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0395","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1085-5629(99)80036-4","article-title":"Recent advances in soft tissue augmentation","volume":"18","author":"Krauss","year":"1999","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0400","doi-asserted-by":"crossref","first-page":"92S","DOI":"10.1097\/01.prs.0000234672.69287.77","article-title":"Avoiding and treating dermal filler complications","volume":"118","author":"Lemperle","year":"2006","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0410","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF01570347","article-title":"Injectable collagen: a six-year clinical investigation","volume":"9","author":"Cooperman","year":"1985","journal-title":"Aesthetic Plast Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0415","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0267-6605(92)90095-B","article-title":"Clinical use of injectable bovine collagen: a decade of experience","volume":"9","author":"Keefe","year":"1992","journal-title":"Clin Mater"},{"issue":"Suppl 2","key":"10.1016\/j.clindermatol.2011.08.005_bb0420","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1111\/j.1524-4725.2009.01349.x","article-title":"Granulomatous foreign body reaction to hyaluronic acid: report of a case after melolabial fold augmentation and review of management","volume":"35","author":"Sage","year":"2009","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0425","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.tripleo.2009.03.032","article-title":"Foreign body granulomatous reactions to cosmetic fillers: a clinical study of 15 cases","volume":"108","author":"Sanchis-Bielsa","year":"2009","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0430","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1468-3083.2007.02354.x","article-title":"Delayed immune-mediated adverse effects related to hyaluronic acid and acrylic hydrogel dermal fillers: clinical findings, long-term follow-up and review of the literature","volume":"22","author":"Alijotas-Reig","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0435","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/09546630601121052","article-title":"Cutaneous granulomatous reaction to injectable hyaluronic acid gel: another case","volume":"18","author":"Bardazzi","year":"2007","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0440","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.asj.2005.07.007","article-title":"Immediate and delayed hypersensitivity reactions to restylane","volume":"25","author":"Bellman","year":"2005","journal-title":"Aesthet Surg J"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0445","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.asj.2005.05.009","article-title":"Hyaluronic acid gel fillers: hypersensitivity reactions","volume":"25","author":"Grossman","year":"2005","journal-title":"Aesthet Surg J"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0450","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1055\/s-2004-822955","article-title":"Review of injectable materials for soft tissue augmentation","volume":"20","author":"Homicz","year":"2004","journal-title":"Facial Plast Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0455","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1055\/s-0029-1220647","article-title":"Hyaluronic acid fillers: a comprehensive review","volume":"25","author":"Beasley","year":"2009","journal-title":"Facial Plast Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0460","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2147\/CIA.S3118","article-title":"Hyaluronic acid gel (Juv\u00e9derm) preparations in the treatment of facial wrinkles and folds","volume":"3","author":"Bogdan Allemann","year":"2008","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0465","author":"The American Society for Aesthetic Plastic Surgery"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0470","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/jbm.820270903","article-title":"Hylan gel biomaterial: dermal and immunologic compatibility","volume":"27","author":"Larsen","year":"1993","journal-title":"J Biomed Mater Res"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0475","first-page":"178","article-title":"Exudative granulomatous reaction to hyaluronic acid (Hylaform)","volume":"43","author":"Raulin","year":"2000","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0480","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1067\/mjd.2001.117381","article-title":"Hyaluronic acid skin fillers: adverse reactions and skin testing","volume":"45","author":"Lowe","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0485","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1046\/j.1524-4725.2002.01251.x","article-title":"Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation","volume":"28","author":"Friedman","year":"2002","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0490","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1524-4725.2000.99202.x","article-title":"Cutaneous hypersensitivity reaction to injectable hyaluronic acid gel","volume":"26","author":"Lupton","year":"2000","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0495","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bjps.2008.06.036","article-title":"Injectable fillers for facial rejuvenation: a review","volume":"62","author":"Buck","year":"2009","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0500","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1046\/j.1524-4725.2003.29140.x","article-title":"Soft tissue augmentation with artecoll: 10-year history, indications, techniques, and complications","volume":"29","author":"Lemperle","year":"2003","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0505","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2010.02.064","article-title":"Adverse reactions to injectable soft tissue fillers","volume":"64","author":"Requena","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 2","key":"10.1016\/j.clindermatol.2011.08.005_bb0510","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1111\/j.1524-4725.2009.01335.x","article-title":"Recommendations and treatment options for nodules and other filler complications","volume":"35","author":"Narins","year":"2009","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0515","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1097\/PRS.0b013e3181cb4620","article-title":"Soft-tissue filler complications: the important role of biofilms","volume":"125","author":"Rohrich","year":"2010","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0520","doi-asserted-by":"crossref","first-page":"5993","DOI":"10.1128\/JB.181.19.5993-6002.1999","article-title":"Abiotic surface sensing and biofilm-dependent regulation of gene expression in Escherichia coli","volume":"181","author":"Prigent-Combaret","year":"1999","journal-title":"J Bacteriol"},{"issue":"Suppl 1","key":"10.1016\/j.clindermatol.2011.08.005_bb0525","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1111\/j.1524-4725.2008.34250.x","article-title":"Minimizing adverse events associated with poly-L-lactic acid injection","volume":"34","author":"Narins","year":"2008","journal-title":"Dermatol Surg"},{"issue":"Suppl 2","key":"10.1016\/j.clindermatol.2011.08.005_bb0530","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/j.1524-4725.2009.01347.x","article-title":"Electron microscopic documentation of late changes in permanent fillers and clinical management of granulomas in affected patients","volume":"35","author":"Wiest","year":"2009","journal-title":"Dermatol Surg"},{"issue":"Suppl 2","key":"10.1016\/j.clindermatol.2011.08.005_bb0535","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1111\/j.1524-4725.2009.01338.x","article-title":"Host tissue interaction, fate, and risks of degradable and nondegradable gel fillers","volume":"35","author":"Christensen","year":"2009","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0540","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1524-4725.2009.01419.x","article-title":"Cosmetic use of poly-l-lactic acid: a retrospective study of 130 patients","volume":"36","author":"Palm","year":"2010","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0545","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1524-4725.2007.33123.x","article-title":"The natural history of polymethylmethacrylate microspheres granulomas","volume":"33","author":"Gelfer","year":"2007","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0550","first-page":"CD004288","article-title":"Surgical hand antisepsis to reduce surgical site infection","author":"Tanner","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0555","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/00129804-200207000-00007","article-title":"A clinical study comparing the skin antisepsis and safety of ChloraPrep, 70% isopropyl alcohol, and 2% aqueous chlorhexidine","volume":"25","author":"Hibbard","year":"2002","journal-title":"J Infus Nurs"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0560","first-page":"13","article-title":"Anatomic considerations for soft tissue augmentation of the face","volume":"8","author":"Cohen","year":"2009","journal-title":"J Drugs Dermatol"},{"issue":"Suppl 2","key":"10.1016\/j.clindermatol.2011.08.005_bb0565","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1111\/j.1524-4725.2009.01342.x","article-title":"The risk of alar necrosis associated with dermal filler injection","volume":"35","author":"Grunebaum","year":"2009","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0570","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s00266-008-9281-0","article-title":"Injectable calcium hydroxylapatite for correction of nasal bridge deformities","volume":"33","author":"Siclovan","year":"2009","journal-title":"Aesthetic Plast Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0575","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1046\/j.1365-2133.2002.04707.x","article-title":"Arterial embolization caused by injection of hyaluronic acid (Restylane)","volume":"146","author":"Schanz","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0580","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1524-4725.2007.33228.x","article-title":"Infraorbital hollow treatment by dermal fillers","volume":"33","author":"Hirsch","year":"2007","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0585","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/lsm.20283","article-title":"Management of injected hyaluronic acid induced Tyndall effects","volume":"38","author":"Hirsch","year":"2006","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0590","first-page":"281","article-title":"Fast and easy treatment for reduction of the Tyndall effect secondary to cosmetic use of hyaluronic acid","volume":"7","author":"Douse-Dean","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0595","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1080\/14764170701291674","article-title":"Hyaluronidase in the office: a necessity for every dermasurgeon that injects hyaluronic acid","volume":"9","author":"Hirsch","year":"2007","journal-title":"J Cosmet Laser Ther"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0600","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/j.1524-4725.2010.01585.x","volume":"36","author":"Lee","year":"2010","journal-title":"Hyaluronidase. Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0605","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/01.PRS.0000127250.35248.56","article-title":"The use of hyaluronidase to reverse the effects of hyaluronic acid filler","volume":"114","author":"Lambros","year":"2004","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0610","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1524-4725.2005.31801","article-title":"Use of hyaluronidase in the treatment of granulomatous hyaluronic acid reactions or unwanted hyaluronic acid misplacement","volume":"31","author":"Brody","year":"2005","journal-title":"Dermatol Surg"},{"issue":"Suppl 1","key":"10.1016\/j.clindermatol.2011.08.005_bb0615","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1111\/j.1524-4725.2008.34247.x","article-title":"Radiographic and computed tomographic studies of calcium hydroxylapatite for treatment of HIV-associated facial lipoatrophy and correction of nasolabial folds","volume":"34","author":"Carruthers","year":"2008","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0620","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1001\/archfaci.10.5.335","article-title":"Soft-tissue augmentation with calcium hydroxylapatite: histological analysis","volume":"10","author":"Holzapfel","year":"2008","journal-title":"Arch Facial Plast Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0625","first-page":"846","article-title":"Radiesse nodule of the lips from a distant injection site: report of a case and consideration of etiology and management","volume":"6","author":"Beer","year":"2007","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0630","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1055\/s-0029-1220649","article-title":"Injectable calcium hydroxylapatite microspheres (Radiesse)","volume":"25","author":"Ridenour","year":"2009","journal-title":"Facial Plast Surg"},{"issue":"Suppl 2","key":"10.1016\/j.clindermatol.2011.08.005_bb0635","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1111\/j.1524-4725.2007.33351.x","article-title":"A multicenter, 47-month study of safety and efficacy of calcium hydroxylapatite for soft tissue augmentation of nasolabial folds and other areas of the face","volume":"33","author":"Sadick","year":"2007","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0640","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1001\/archfaci.6.4.234","article-title":"Evaluation of the Radiance FN soft tissue filler for facial soft tissue augmentation","volume":"6","author":"Tzikas","year":"2004","journal-title":"Arch Facial Plast Surg"},{"issue":"Suppl 1","key":"10.1016\/j.clindermatol.2011.08.005_bb0645","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1111\/j.1524-4725.2008.34238.x","article-title":"An investigation of changes in physical properties of injectable calcium hydroxylapatite in a carrier gel when mixed with lidocaine and with lidocaine\/epinephrine","volume":"34","author":"Busso","year":"2008","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0650","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/1090820X10391213","article-title":"Nonsurgical rejuvenation of the aging face with injectable poly-L-lactic acid for restoration of soft tissue volume","volume":"31","author":"Schierle","year":"2011","journal-title":"Aesthet Surg J"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0660","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jaad.2004.08.056","article-title":"Assessment of the safety and efficacy of poly-L-lactic acid for the treatment of HIV-associated facial lipoatrophy","volume":"52","author":"Burgess","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0665","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1468-1293.2006.00342.x","article-title":"Long-term safety and efficacy of poly-L-lactic acid in the treatment of HIV-related facial lipoatrophy","volume":"7","author":"Moyle","year":"2006","journal-title":"HIV Med"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0670","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1097\/00002030-200311210-00009","article-title":"Polylactic acid implants (New-Fill) to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA","volume":"17","author":"Valantin","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0675","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jaad.2008.07.027","article-title":"Treatment of HIV lipoatrophy and lipoatrophy of aging with poly-L-lactic acid: a prospective 3-year follow-up study","volume":"59","author":"Levy","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0680","doi-asserted-by":"crossref","first-page":"55S","DOI":"10.1097\/01.prs.0000234612.20611.5a","article-title":"Injectable poly-L-lactic acid (Sculptra): technical considerations in soft-tissue contouring","volume":"118","author":"Lam","year":"2006","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0685","first-page":"385","article-title":"Poly-L-lactic acid: a temporary filler for soft tissue augmentation","volume":"3","author":"Woerle","year":"2004","journal-title":"J Drugs Dermatol"},{"issue":"Suppl 1","key":"10.1016\/j.clindermatol.2011.08.005_bb0690","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1524-4725.2008.01043.x","article-title":"Clinicopathologic correlation of delayed-onset periorbital poly-L-lactic acid nodules","volume":"35","author":"Beer","year":"2009","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0695","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1473-2165.2007.00303.x","article-title":"Adverse reactions to polylactic acid injections in the periorbital area","volume":"6","author":"Apikian","year":"2007","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0700","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/00006534-199509000-00015","article-title":"PMMA microspheres (Artecoll) for skin and soft-tissue augmentation. Part II: clinical investigations","volume":"96","author":"Lemperle","year":"1995","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0705","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s00266-003-3022-1","article-title":"Human histology and persistence of various injectable filler substances for soft tissue augmentation","volume":"27","author":"Lemperle","year":"2003","journal-title":"Aesthetic Plast Surg"},{"key":"10.1016\/j.clindermatol.2011.08.005_bb0710","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1097\/00006534-199711000-00014","article-title":"Evaluation of artecoll polymethylmethacrylate implant for soft-tissue augmentation: biocompatibility and chemical characterization","volume":"100","author":"McClelland","year":"1997","journal-title":"Plast Reconstr Surg"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X11002094?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X11002094?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T22:46:21Z","timestamp":1713048381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X11002094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":138,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0738081X11002094"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2011.08.005","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}